Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
Product Unit Size | Cost | Quantity | Stock |
---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
Cas No. | 1258595-14-0 |
---|---|
Purity | ≥99% |
Formula | C29H32F2N3O7P |
Formula Wt. | 603.56 |
IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
Synonym | LHC165 |
Appearance | Pale yellow powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
EZH2 HMT inhibitor.
AT1 inhibitor.
Endogenous peptide hormone, involved in feeding...
Piroxicam prodrug, NSAID; COX-1/2 inhibitor.
Cysteine-ITC conjugate, antioxidant.
Fibrate; PPARα agonist.
Synthetic antioxidant that induces phase II enz...
D2 and 5-HT1A partial agonist, 5-HT2C/6/7 antag...
Synthetic isoflavone.
Endogenous cardiomodulatory peptide; NPR-A agon...
Triphenylthylene, tamoxifen analog; SERM.
PDE3 inhibitor.
Podophyllotoxin derivative found in Podophyllum...
Diterpene found in Taxus; potential microtubule...
Triterpene saponin found in Bupleurum.
NK1 antagonist.
Organosulfur found in garlic; Microtubule polym...
Isoflavone daidzein derivative found in Puerari...
Endogenous proneurotensin peptide, involved in ...
Tetrapeptide, binds cell surface integrins.